Literature DB >> 30032985

Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.

Eveline Boudin1, Tjeerd R de Jong2, Tim C R Prickett3, Bruno Lapauw4, Kaatje Toye4, Viviane Van Hoof5, Ilse Luyckx1, Aline Verstraeten1, Hugo S A Heymans6, Eelco Dulfer7, Lut Van Laer1, Ian R Berry8, Angus Dobbie9, Ed Blair10, Bart Loeys1, Eric A Espiner3, Jan M Wit11, Wim Van Hul1, Peter Houpt2, Geert R Mortier12.   

Abstract

The natriuretic peptide signaling pathway has been implicated in many cellular processes, including endochondral ossification and bone growth. More precisely, different mutations in the NPR-B receptor and the CNP ligand have been identified in individuals with either short or tall stature. In this study we show that the NPR-C receptor (encoded by NPR3) is also important for the regulation of linear bone growth. We report four individuals, originating from three different families, with a phenotype characterized by tall stature, long digits, and extra epiphyses in the hands and feet. In addition, aortic dilatation was observed in two of these families. In each affected individual, we identified a bi-allelic loss-of-function mutation in NPR3. The missense mutations (c.442T>C [p.Ser148Pro] and c.1088A>T [p.Asp363Val]) resulted in intracellular retention of the NPR-C receptor and absent localization on the plasma membrane, whereas the nonsense mutation (c.1524delC [p.Tyr508∗]) resulted in nonsense-mediated mRNA decay. Biochemical analysis of plasma from two affected and unrelated individuals revealed a reduced NTproNP/NP ratio for all ligands and also high cGMP levels. These data strongly suggest a reduced clearance of natriuretic peptides by the defective NPR-C receptor and consequently increased activity of the NPR-A/B receptors. In conclusion, this study demonstrates that loss-of-function mutations in NPR3 result in increased NPR-A/B signaling activity and cause a phenotype marked by enhanced bone growth and cardiovascular abnormalities.
Copyright © 2018 American Society of Human Genetics. All rights reserved.

Entities:  

Keywords:  NPR3; aortic dilatation; extra epiphyses; natriuretic peptide signaling; tall stature

Mesh:

Substances:

Year:  2018        PMID: 30032985      PMCID: PMC6080727          DOI: 10.1016/j.ajhg.2018.06.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  57 in total

Review 1.  Receptors of atrial natriuretic factor.

Authors:  T Maack
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

2.  Complete pseudoepiphyses with associated enhanced growth in hands and feet: a report of 2 siblings--case report.

Authors:  Tjeerd R de Jong; Wynand B W H Melenhorst; Peter Houpt
Journal:  J Hand Surg Am       Date:  2014-03       Impact factor: 2.230

3.  Localization of C-type natriuretic peptide mRNA in rat hypothalamus.

Authors:  J P Herman; M C Langub; R E Watson
Journal:  Endocrinology       Date:  1993-10       Impact factor: 4.736

4.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

Authors:  S Suga; K Nakao; H Itoh; Y Komatsu; Y Ogawa; N Hama; H Imura
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Impact of age, phenotype and cardio-renal function on plasma C-type and B-type natriuretic peptide forms in an adult population.

Authors:  T C R Prickett; R C Olney; V A Cameron; M J Ellis; A M Richards; E A Espiner
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05       Impact factor: 3.478

6.  Short-limbed dwarfism: slw is a new allele of Npr2 causing chondrodysplasia.

Authors:  Chizuru Sogawa; Takehito Tsuji; Yusuke Shinkai; Kentaro Katayama; Tetsuo Kunieda
Journal:  J Hered       Date:  2007-08-28       Impact factor: 2.645

7.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Authors:  S Suga; K Nakao; K Hosoda; M Mukoyama; Y Ogawa; G Shirakami; H Arai; Y Saito; Y Kambayashi; K Inouye
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

Review 8.  Corin: new insights into the natriuretic peptide system.

Authors:  Qingyu Wu; Ye Olivia Xu-Cai; Shenghan Chen; Wei Wang
Journal:  Kidney Int       Date:  2008-08-20       Impact factor: 10.612

9.  Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size.

Authors:  Nicole Soranzo; Fernando Rivadeneira; Usha Chinappen-Horsley; Ida Malkina; J Brent Richards; Naomi Hammond; Lisette Stolk; Alexandra Nica; Michael Inouye; Albert Hofman; Jonathan Stephens; Eleanor Wheeler; Pascal Arp; Rhian Gwilliam; P Mila Jhamai; Simon Potter; Amy Chaney; Mohammed J R Ghori; Radhi Ravindrarajah; Sergey Ermakov; Karol Estrada; Huibert A P Pols; Frances M Williams; Wendy L McArdle; Joyce B van Meurs; Ruth J F Loos; Emmanouil T Dermitzakis; Kourosh R Ahmadi; Deborah J Hart; Willem H Ouwehand; Nicholas J Wareham; Inês Barroso; Manjinder S Sandhu; David P Strachan; Gregory Livshits; Timothy D Spector; André G Uitterlinden; Panos Deloukas
Journal:  PLoS Genet       Date:  2009-04-03       Impact factor: 5.917

10.  Characterization of two ENU-induced mutations affecting mouse skeletal morphology.

Authors:  Shauna M Dauphinee; Megan M Eva; Kyoko E Yuki; Melissa Herman; Silvia M Vidal; Danielle Malo
Journal:  G3 (Bethesda)       Date:  2013-10-03       Impact factor: 3.154

View more
  7 in total

Review 1.  CNP-related Short and Tall Stature: A Close-knit Family of Growth Disorders.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  J Endocr Soc       Date:  2022-04-16

2.  Prioritization of Osteoporosis-Associated Genome-wide Association Study (GWAS) Single-Nucleotide Polymorphisms (SNPs) Using Epigenomics and Transcriptomics.

Authors:  Xiao Zhang; Hong-Wen Deng; Hui Shen; Melanie Ehrlich
Journal:  JBMR Plus       Date:  2021-03-19

3.  Phen2Gene: rapid phenotype-driven gene prioritization for rare diseases.

Authors:  Mengge Zhao; James M Havrilla; Li Fang; Ying Chen; Jacqueline Peng; Cong Liu; Chao Wu; Mahdi Sarmady; Pablo Botas; Julián Isla; Gholson J Lyon; Chunhua Weng; Kai Wang
Journal:  NAR Genom Bioinform       Date:  2020-05-25

4.  Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.

Authors:  Brandon M Wagner; Jerid W Robinson; Yun-Wen Lin; Yi-Ching Lee; Nabil Kaci; Laurence Legeai-Mallet; Lincoln R Potter
Journal:  JCI Insight       Date:  2021-05-10

5.  Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia.

Authors:  Timothy C R Prickett; Eric A Espiner; Melita Irving; Carlos Bacino; John A Phillips; Ravi Savarirayan; Jonathan R S Day; Elena Fisheleva; Kevin Larimore; Ming Liang Chan; George S Jeha
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

6.  Broadening the Spectrum of Loss-of-Function Variants in NPR-C-Related Extreme Tall Stature.

Authors:  Peter Lauffer; Eveline Boudin; Daniëlle C M van der Kaay; Saskia Koene; Arie van Haeringen; Vera van Tellingen; Wim Van Hul; Timothy C R Prickett; Geert Mortier; Eric A Espiner; Hermine A van Duyvenvoorde
Journal:  J Endocr Soc       Date:  2022-02-10

7.  An Activating Deletion Variant in the Submembrane Region of Natriuretic Peptide Receptor-B Causes Tall Stature.

Authors:  Peter Lauffer; Erick Miranda-Laferte; Hermine A van Duyvenvoorde; Arie van Haeringen; Franziska Werner; Eveline Boudin; Hannes Schmidt; Thomas D Mueller; Michaela Kuhn; Daniëlle C M van der Kaay
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.